Stryker (NYSE: SYK) VP, controller discloses 5,538 stock options
Stryker (SYK) VP and Corporate Controller Emily Kay Baculik reported initial holdings of 5,538 stock options and 1,554 shares of common stock, including 20 shares indirectly. Options were granted under the 2011 Long-Term Incentive Plan, exercisable in 20% increments over five years, with exercise prices ranging from $248.60 to $392.39 and expirations between 2032 and 2036.
How this was made
The 30-second read
Why it matters
The disclosure adds a new data point on insider ownership but lacks material trading relevance.
Market read
Limited relevance; primarily of interest to compliance and insider tracking.
What to watch
Potential future vesting of options could align management incentives over the long term.
Background
SEC Form 3 filing for Stryker's corporate controller reporting initial equity awards under the 2011 Long-Term Incentive Plan.
Ticker impact
Form 3 filing discloses VP Emily Kay Baculik's stock option and share holdings at Stryker.
minimal effect on price
The filing reports small option grants and shares; no buy or sell activity is indicated.
Market effects
None; insider holding does not affect medical device sector broadly.
None; limited to Stryker investors.
None
Counterpoint
Even small insider holdings can signal confidence, but size is too trivial to act on.
Key entities
- personEmily Kay Baculik
VP, Corporate Controller at Stryker
- companyStryker Corp
Medical device manufacturer (NYSE: SYK)
